Skip to main navigation Skip to search Skip to main content

Development of Specific Inhibitors for Breast Cancer-Associated Variants of ErbB2

Project: Research

Project Details

StatusFinished
Effective start/end date09/26/14 → 09/25/18

Funding

  • US Army Medical Research Acquisition Activity: $309,758.00